0HVB.LSE Centene Corp.
- Market cap
- -
- P/E
- 26.5x
- P/B
- -
- ROE
- 15.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 0HVB.LSE undervalued?
Graham numberThe Graham number of Centene Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Centene Corp. fundamental analysis
No fundamental analysis for Centene Corp. yet.
Centene Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Centene Corp.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-m…
Full company profileCentene Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Centene Corp. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 40.6B | 48.4B | 60.1B | 74.6B | 111B | 119B | 145B | 141B | 163B | 195B | 206B |
| Gross Profit | 37.7B | 45.8B | 56.7B | 70.8B | 104B | 118B | 136B | 154B | 147B | 37.1B | 47.6B |
| Operating Income | 1.61B | 1.47B | 2.13B | 2.58B | 3.73B | 3.49B | 3.86B | 3.62B | 3.28B | -284M | 3.67B |
| EBITDA | 1.65B | 1.75B | 2.21B | 2.84B | 4.76B | 3.95B | 4.06B | 5.62B | 4.96B | -4.78B | 6.44B |
| Net Income | 562M | 828M | 900M | 1.32B | 1.81B | 1.35B | 1.20B | 2.70B | 3.31B | -6.67B | 3.41B |
| EPS | 1.71 | 2.34 | 2.26 | 3.14 | 3.12 | 2.28 | 2.07 | 4.95 | 6.31 | -14 | 6.91 |
| Balance Sheet | |||||||||||
| Total Assets | 20.2B | 21.9B | 30.9B | 41.0B | 69.8B | 79.8B | 78.5B | 85.9B | 83.6B | 77.7B | 79.3B |
| Total Liabilities | 14.1B | 15.0B | 19.9B | 28.3B | 43.9B | 52.7B | 54.3B | 59.9B | 57.1B | 57.6B | 57.0B |
| Shareholders' Equity | 5.90B | 6.85B | 10.9B | 12.6B | 25.8B | 26.8B | 24.1B | 25.8B | 26.4B | 20.0B | 22.2B |
| Cash & Short-term Investments | 3.93B | 4.07B | 5.34B | 12.1B | 10.8B | 13.1B | 12.1B | 17.2B | 14.1B | 17.9B | 20.7B |
| Total Debt | 4.66B | 4.70B | 6.69B | 14.5B | 18.3B | 22.7B | 21.3B | 17.7B | 19.4B | 18.8B | 15.5B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.85B | 1.49B | 1.23B | 1.48B | 5.50B | 4.21B | 6.26B | 8.05B | 154M | 5.09B | 5.72B |
| Capital Expenditure | 306M | 422M | 675M | 730M | 869M | 910M | 1.00B | 799M | 644M | 767M | 757M |
| Free Cash Flow | 1.55B | 1.07B | 559M | 753M | 4.63B | 3.30B | 5.26B | 7.25B | -490M | 4.32B | 4.96B |
| Ratios | |||||||||||
| ROE | 9.5% | 12.1% | 8.2% | 10.5% | 7.0% | 5.0% | 5.0% | 10.5% | 12.5% | -33.4% | 15.4% |
| ROA | 2.8% | 3.8% | 2.9% | 3.2% | 2.6% | 1.7% | 1.5% | 3.1% | 4.0% | -8.6% | 4.3% |
| Net Profit Margin | 1.4% | 1.7% | 1.5% | 1.8% | 1.6% | 1.1% | 0.8% | 1.9% | 2.0% | -3.4% | 1.7% |
| Debt to Equity | 0.79x | 0.69x | 0.61x | 1.16x | 0.71x | 0.85x | 0.89x | 0.68x | 0.74x | 0.94x | 0.70x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Centene Corp. dividends
Centene Corp. has not paid dividends in the last 9 fiscal years.
Last stock split: 2:1 on Feb 7, 2019.
Who owns Centene Corp.
- Insiders 0.39%
- Institutions 99.61%
- Public & others 0.00%
- Free float 465M
Centene Corp. company profile
- Company name
- Centene Corp.
- Ticker
- 0HVB.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 61,100
- Fiscal year end
- December
- Address
- Centene Plaza, Saint Louis, MO, United States, 63105
- Phone
- 314 725 4477
- Website
- centene.com
About Centene Corp.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Centene Corp. management
10- Ms. Sarah M. LondonCEO & Director · born 1981
- Mr. Andrew Lynn AsherExecutive VP & CFO · born 1969
- Ms. Susan R. SmithChief Operating Officer · born 1976
- Mr. Christopher Andrew KosterExecutive VP, General Counsel & Secretary · born 1965
- Ms. Tanya M. McNallySenior VP & Chief People Officer · born 1974
- Mr. Theodore Joseph PienkosCorporate Controller & Chief Accounting Officer · born 1982
- Mr. Bradley BolivarChief Information Officer
- Ms. Jennifer Lynch GilliganSenior Vice President of Investor Relations
- Ms. Ashlee KnuckeyChief Risk, Ethics & Compliance Officer
- Sara GarlandChief Communications Officer